Inventory of vocal cord lesions causing dysphonia in autoimmune disease patients
Official title: Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases.
Run by University Hospital, Brest · NCT06779799 · Data updated 2026-11-12
This study looks at the types of vocal cord problems that cause voice issues in people with autoimmune diseases to help improve their diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | May 31, 2025 |
| Study ends | May 31, 2025 |
| Registry record updated | January 17, 2025 |
| Trial ID | NCT06779799 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a systemic autoimmune disease who are experiencing dysphonia and have identifiable vocal cord lesions.
✕Probably not a fit
Patients with dysphonia due to neurological conditions, malignancies, or those under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter retrospective observational study aims to catalog the specific and non-specific vocal cord lesions that lead to dysphonia in patients with systemic autoimmune diseases. It will identify participants suffering from dysphonia and review their medical records to determine the main lesions responsible, any delays in diagnosis, and management strategies. The study focuses on conditions such as rheumatoid arthritis and systemic lupus erythematosus, exploring lesions like 'bamboo nodes' and other irritative factors. The findings could help improve understanding and management of dysphonia in this patient population.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of dysphonia in patients with systemic autoimmune diseases.
How similar studies have gone: While there have been small series reported on similar conditions, this study aims to provide a more comprehensive inventory, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older * With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome. * Suffering from dysphonia. * With a cord vocal/laryngeal lesion highlighted. Exclusion Criteria: * Patients under the age of 18 years * Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy * History of cervical radiation * History of oro-tracheal intubation * Laryngeal cancer * Participation deny * Impossibility of consent * Patients with legal protection
Where it's running
-
Chu Brest
Brest, France Recruiting
Study contacts
- Study coordinator: Alice TISON
- Email: alice.tison@chu-brest.fr
- Phone: 0298347264
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ocular Symptoms in ANCA-Associated Vasculitis
This study tests ocular changes in adults with GPA, MPA, or related vasculitis to see how the eyes are involved.
-
Systemic Vasculitis Prognosis and Outcome
This study follows patients suspected or diagnosed with systemic vasculitis over 10 years to see how their disease progresses and what factors predict outcomes.
-
Heart Institute Biobank and Registry for Adults with Congenital Heart Disease and Related Conditions
This project will collect blood, tissue samples, and detailed health information from adults (≥16) with congenital heart disease and related heart or vascular conditions to create a resource researchers can use.
-
Reducing unnecessary medications in older adults with rheumatic conditions
This project will test whether giving doctors individualized MedSafer reports plus patient EMPOWER brochures helps people 60+ with rheumatic conditions who take five or more regular medications stop or reduce risky medicines.
-
Conversation-first versus step-by-step voice therapy to improve everyday speaking
We will test whether starting voice therapy with real conversations (Conversation Training Therapy) versus a traditional step-by-step approach gives better 12-month voice outcomes for adults with muscle tension dysphonia or benign vocal fold lesions.
-
Surgery versus home care for painful wrist ganglion
This trial will test whether surgery or simple home exercises and using the hand as tolerated helps adults with a painful wrist ganglion feel and function better over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.